The technology sector tumbled as mounting worries over heavy capital investments in artificial intelligence and data-center expansion rattled markets. The drop completely wiped out the gains achieved in the prior session, which had been sparked by a Democratic sweep of both houses of Congress. Market participants are now growing increasingly uneasy that this political shift could lead to enhanced government oversight of the ongoing AI infrastructure buildout.
Key points
A ten percent decline from a recent record close officially meets the widely accepted def…: A ten percent decline from a recent record close officially meets the widely accepted definition of a market correction.
The sharp sell-off completely wiped out all the stock market gains achieved during the pr…: The sharp sell-off completely wiped out all the stock market gains achieved during the previous trading session.
Growing anxiety over elevated AI expenditures and potential oversight of data-center expa…: Growing anxiety over elevated AI expenditures and potential oversight of data-center expansions continues to pressure tech equities.
Sources checked by our analysis pipeline: 1
Nov 5 : The Nasdaq slid 10 per cent from its record close on Thursday, on pace to confirm a correction as AI spending worries and heightened scrutiny of data-center expansion rattled tech stocks.
The tech-heavy Nasdaq Composite Index slipped 3.2 per cent to 24,796.06 points, down 10 per cent from its record-closing high of 27,599.89, reached on October 6.
Thursday's move wiped out all the gains the index had logged in the previous session following a the Democrat sweep of both houses of Congress as investors fretted about increasing scrutiny on further AI buildout.
A drop of a 10 per cent from the most recent record-closing high is considered a correction based on a widely used definition. The move would mark a second correction for the index this year.
Strong patient demand for generic medications and specialty therapeutics drove robust profit growth, prompting leadership to boost its full-year earnings guidance. A high-performing pharmaceutical core offset persistent weakness in secondary logistics and supply divisions. Consequently, the healthcare distributor's shares advanced over 3% amid a wider market retreat.
Public sector undertakings and major technology corporations are driving significant cash returns for domestic equity investors through sustained high dividend distributions. While these regular payouts offer substantial yields relative to current share prices, underlying capital appreciation varies widely across the featured businesses. Consequently, strong cash distributions have partially offset share price declines for certain state-run firms, while technology and energy leaders managed to pair payouts with po…
Democratic victories in the U.S. midterm elections have triggered widespread regulatory concerns across the artificial intelligence sector, prompting severe sell-offs in major tech equities. Markets are reacting sharply to political shifts, particularly after significant political investments failed to prevent local opposition to critical computing infrastructure. This unexpected electoral outcome has intensified broader fears that AI valuations are due for a substantial market correction.